Editors/Authors   Librarians   Newsletter   Site Tour   Subscriptions   A-Z Index   About   Contact Us   Help 
Log In | Log In via Athens
 
Disable Autosuggest
The Rational Clinical Examination
David L. Simel, Drummond Rennie
Erythema Migrans
Carrie D. Tibbles, Jonathan A. Edlow
Clinical Scenario


Topics Discussed: borrelia burgdorferi, erythema migrans, lyme disease, tick bite, ticks

Excerpt: "A 22-year old man presents to the emergency department with a red rash on his left shoulder. The rash is slightly itchy and has increased in size since he first noticed it, 3 days ago. It is July, and he has been working outdoors in New Jersey, but does not recall a tick bite. He is afebrile. The rash is a flat oval homogeneous erythema, 14 cm along its long axis, without central clearing (Figure 61-2). Other than a small minimally tender 1.5 x 1.5-cm lymph node in the left axilla, his physical examination is normal. You think that erythema migrans is a strong possibility and consider treating him without any further testing.In 1908, the Swedish dermatologist Afezelius1 described erythema migrans as an expanding erythema with central clearing that occurred at the site of a bite of the European sheep tick Ixodes ricinus. Over the ensuing decades, European investigators documented the details of the rash (previously referred to as erythema chronicum migrans), its association with tick bites, its responsiveness to antibiotics, and its association with other manifestations of what is now known as Lyme disease or Lyme borreliosis.1 The term Lyme arthritis was coined in the late 1970s after an investigation of a statistically improbable cluster of what had been erroneously diagnosed as juvenile rheumatoid arthritis in the Lyme, Conn, area. This investigation, headed by a team from Yale University, focused on the arthritis, but it soon became clear that cardiac, neurological, skin, and other manifestations were part of a systemic disease transmitted by the bite of an Ixodes scapularis tick.2–4 In 1982, Burgdorfer5 and colleagues at the National Institutes of Health Rocky Mountain Laboratory discovered the causative agent, a novel bacterium, Borrelia burgdorferi (sensu stricto). Shortly thereafter, 2 closely related spirochetes, Borrelia afzelii and Borrelia garinii, were isolated from European cases of erythema migrans.6,7 Collectively, these 3 bacteria are termed B burgdorferi, sensu lato. For years, erythema migrans was considered to be pathognomonic of Lyme disease. However, recent reports of erythema migrans–like rashes in nonendemic areas of the United States have called that concept into question...."
Log in to read the full chapter:
Subscriber Log In
Username:
Password:
Forgot your username/password?
Or  
Get full access to JAMAevidence two ways:
Subscribe to JAMAevidence
JAMAevidence is a subscription-
based website dedicated to the learning, teaching, and practicing of evidence-based medicine.
Pay Per View
Timed access to all of JAMAevidence
24 hours for $29.95
48 hours for $49.95
Copyright © American Medical Association. All rights reserved.  |  JAMA  |  McGraw-Hill Global Education Holdings, LLC.
Privacy Notice. Any use is subject to the Terms of Use and Notice. Additional Credits and Copyright Information.
Your IP address is 107.21.186.38